|
Protecting against Breast Cancer Every
woman is concerned about breast cancer risk for herself and her loved ones. Breast cancer is the most common cancer to affect women. In 2003, there were about 200,000 new cases of breast cancer in the United
States. Risk increases as one gets older, with a one in eight lifetime risk if one lives until 90. With aggressive preventative testing, which continues to advance beyond mammograms, sonograms, and MRI's,
80% of women diagnosed now are found at a relatively early stage, with a good prognosis. In Manhattan, where the patients tend to be more involved in their healthcare, and the mammograms and sonograms tend to be
high-quality, the incidence of early diagnosis and good prognosis is even higher.So what can we do to identify and reduce our risk for breast cancer? Obviously, the greater the risk, the more
aggressive we should be in terms of utilizing, screening, diet, supplementation, and any other modality to reduce tour odds.
- Growing older
is the biggest risk factor for developing breast cancer. Wear and tear increases the likelihood that a genetic error will be made, that will not be recognized by the body, which will cause breast cell to reproduce themselves at too rapid a rate.
- From birth to age 39, 1 woman in 231 will get breast cancer (<0.5% risk).
- From ages 40–59, the chance is 1 in 25 (4% risk).
- From ages 60–79, the chance is 1 in 15 (nearly 7%).
- Personal history of breast cancer
is a risk factor for breast cancer recurrence or the formation of a new breast cancer. In other words, if you have already been diagnosed with breast cancer, your risk of developing it again is higher than if you had never had the disease. The risk is about 1% per year, so that over a 10-year period, your risk would be about 10%. However, there is medication, tamoxifen, available to help you reduce that risk
.
Prolonged, uninterrupted exposure to estrogen
can increase breast cancer risk. Breast cell growth—both normal and abnormal—is stimulated by the presence of estrogen. This includes estrogen that your own body produces normally, as well as estrogen you might take as a pill (for example, menopause hormone therapy). The following risk factors for breast cancer are related to prolonged exposure to estrogen without any breaks or interruptions starting menstruation at a young age (more years of the body producing estrogen),
starting menstruation at a young age.
going through menopause at a late age (more years of the body producing estrogen).
taking hormone therapy for over five years with estrogen alone, or with estrogen and progesterone (risk increases by 5–40%, but most breast cancers that are diagnosed in women on hormone therapy tend to be very
early stage and very treatable).
never having had a full-term pregnancy.
having a first full-term pregnancy after age 30 (more years of the body producing estrogen without the break from regular cycles).
Being overweight, which increases the production of estrogen outside the ovaries and adds to the overall level of estrogen in the body.
Exposure to estrogens in the environment (such as estrogen fed to fatten up beef cattle, or the breakdown products of the pesticide DDT), which mimic the effects of estrogen in the body
Having too much alcohol without enough folic acid intake in the diet.
Family history of breast cancer
can have a significant impact on your risk, but don't automatically assume that any case of breast cancer in your family means you are a high-risk candidate. For example, if your grandmother was diagnosed with breast cancer at age 75, this does NOT mean your risk of the disease is increased. Your grandmother was most likely just one of the 1 in 15 women in that age bracket who gets breast cancer from the wear and tear of aging.
Patterns of family history on your mother's or father's side may suggest a genetic abnormality leading to a higher risk.
- Having a mother, sister, or daughter with breast cancer.
- Having multiple generations of family with breast or ovarian cancer.
- Having relatives with premenopausal breast cancer (prior to age 50).
- Having relatives with bilateral breast cancer.
- You can inherit breast cancer genes, BrCa1 or BrCa2, from either parent. There is a 50% chance of transmission. It is most common in Ashkenazi Jews. Genetic counseling is important if you are
considering testing.
So what can you do to minimize risk of developing breast cancer?
- Keep weight under control. Excess body fat leads to excess estrogen.
- Limit alcohol to a glass of red wine per day, or a glass of grape juice for the Resveratrol. By getting 600mg of folic acid from food or supplements, the alcohol effect is counteracted.
- Exercise, 45 minutes of moderate exercise, 5 days per week may reduce breast cancer risk.
- Phytochemicals in vegetables and fruits may offer protection. A plant-based diet, with brightly-colored, dark green leafy, or cruciferous veggies. Five/day.
- Eat soy containing products.
- Avoid high fat in the diet. Cooked red meat, for example, is a source of carcinogens, including heterocyclic amines, N-nitroso compounds and polycyclic aromatic hydrocarbons, which induce mammary tumors in
animals. And high-fat dairy foods contain fat-soluble hormones or growth factors that might contribute to cancer risk. Grass-fed, hormone-free beef is preferred.
- Frequent self-exams, mammograms, sonograms, possibly a breast MRI, and a relationship with a breast cancer specialist.
Are there Good Supplement Options?
Selenium-- is a micronutrient mineral that seems to be important in
allowing glutathione reductase, the most potent antioxidant in the body, to function efficiently. It is also important in the prevention of prostate cancer. Many parts of the country grow
vegetables in soil depleted of this nutrient, hence it is needed as a supplement. Approximately 100mcg/day. |
Multigenics multivitamin 4/day 100% |
Antioxidants-- Curcumin is a powerful anti-inflammatory compound derived from the spice turmeric. It's important to understand that inflammation stimulates cancer growth and
metastasis; so, safe anti-inflammatory agents are potentially valuable. Test tube studies have found a combination of curcumin and genistein (derived from soy) to completely arrest breast cancer cell
growth. There is a new combination herbal supplement that contains curcumin, green tea, D-Limonene and lycopene. It is called CELAPRO. The combination appears to be much more powerful than the
individual components. Not only is curcumin anti-inflammatory, but also it is an antioxidant, inhibits enzymes that allow tumors to spread, inhibits angiogenesis (formation of new blood vessels necessary
for tumor growth and spread), protects against xenoestrogens (environmental chemicals with estrogenic activity), induces apoptosis and more. Green tea is an antioxidant, inhibits angiogenesis, and
stimulates estrogen elimination from the body. Green tea inhibits cancer in a multitude of other ways. Each capsule of Cell Protect
contains the equivalent of five cups of green tea. D-Limonene is found in essential oils of different fruits and vegetables. It is being studied by the National Cancer Institute as a cancer treatment in humans. D-Limonene increases the activity of carcinogen detoxifying enzymes. It induces apoptosis and causes redifferentiation of tumor cells to more benign forms. In animal studies D-Limonene has been found to not only prevent breast cancer but to cause complete regression of more than 80% of existing breast tumors. Lycopene is an antioxidant that protects cell membranes and DNA against free radical damage. Additionally, lycopene improves intercellular communication and immune function. The lycopene in
celapro is an oil form and is more bioavailable than powdered supplements. |
CELAPRO one tab/day 100% |
Folic acid and B complex
vitamins are found in Multigenics and in Vesselcare. The National Cancer Institute published a study in 2003 that suggested that the B complex vitamins prevented breast cancer, and that folic acid was particularly helpful for protecting against the breast cancer inducing effects of a drink of alcohol per day.
Indole-3-carbinol in broccoli protects against breast cancer as well as prostate cancer. For those who do not eat many cruciferous vegetables, or for those who
want to be aggressive in their efforts, indole-3-carbinol I3C is available. |
META 1C3 two tabs/day 60% |
Vitamin D—is the subject of a great deal of research in both breast
and prostate cancer. Many people are Vitamin D deficient, especially during the winter months. Since we encourage Vit D already for osteoporosis prevention, there are now two good reasons to
take this supplement. |
CAL-APATITE PLUS 100%
(WITH IPRAFLAVONE AND Vit D) 4 tabs/day (900 calcium and 300 vit D) |
Vit E, but not alpha tocopherol has been found to
significantly reduce the risk of premenopausal breast cancer, especially in those who are genetically predisposed. The Nurses Health Study studied 83,234 women at baseline and sought to assess incidences
of breast cancer during a 14 year follow-up. This study showed that premenopausal women with a family history who consumed the highest quantity of vitamin E enjoyed a 43% reduction
in breast cancer incidence compared to only a 16% risk reduction for women without a family history of breast cancer. Based on this study, vitamin E appears to protect against genetic- predisposed breast cancer better than environmental-induced breast cancer. (Note that nutrients like
indole-3-carbinol may specifically protect against environmental breast carcinogens.) |
E-COMPLEX 1:1 2 caps/day 80% |
Isoflavones in soy are phytoestrogens from various plant foods that can
reduce the activity of the body's own estrogens. Rye, flaxseeds, and especially soy are high in phytoestrogens. Phytoestrogens bind to estrogen receptors (including those on breast cells) and exert very weak
estrogenic effects. If a woman is lacking in estrogen, the effect is an increase in estrogenic activity. If a woman has high levels of circulating estrogen, the phytoestrogen, by competing for attachment to
estrogen receptors and exerting a much weaker effect will cause a net decrease in estrogen activity. This is obviously beneficial when estrogen is contributing to breast cancer initiation or promotion. |
SPECTRASOY one tab/day 80% (45mg/isoflavones) |
Aspirin has been associated with a decrease in breast cancer incidence
. The December 2002 issue of the journal Cancer Epidemiology, Biomarkers & Prevention, published the results of a study of 27,616 postmenopausal women that revealed that aspirin, but not other
nonsteroidal anti-inflammatory drugs (NSAIDs), was associated with a reduction in the risk of breast cancer, and that the risk decreased as the frequency of aspirin use increased. Previous epidemiologic
studies have demonstrated a reduction in breast cancer risk with NSAID use but did not separate the effects of aspirin from other NSAIDs. These studies also failed to account for breast cancer risk factors.The study involved participants in the Iowa Women's Health Study, aged 55 to 69, who were followed for six years, during which 983 cases of breast cancer were identified. Information on aspirin
and NSAID use, hormone replacement therapy, smoking status and alcohol intake was obtained via questionnaires completed by mail in 1992. Data concerning other risk factors, such as body mass index, age at
menarche, number of children, age at first live birth and age at menopause, was obtained at the study's onset. The women were followed until the end of 1999. After accounting for age and other
breast cancer risk factors, the use of two to five aspirin per week was associated with a 20% reduction
in the risk of breast cancer compared to those who did not report current usage of the drug. Women who used six or more aspirin per week further lowered their risk. The greatest risk reduction associated with aspirin use was seen in late stage disease and in situ breast cancer. Non-aspirin NSAIDs were not associated with a reduction in breast cancer incidence.
|
One 325mg Aspirin/day if no contraindication |
Conjugated linoleic acid (CLA) is a
dietary fatty acid that improves insulin levels and is associated with a multitude of other health benefits. CLA demonstrates impressive breast-protective effects in test tube and animal studies. It
stimulates the immune system, reduces inflammation, reduces breast cancer formation, inhibits breast cancer progression and growth, induces apoptosis (programmed cell death) in breast cancer cells, and
inhibits breast cancer metastasis (spread to other parts of the body). Breast cancer patients have been found to have lower blood levels of CLA than healthy controls. CLA occurs naturally in beef and
dairy fat (more so in grazing than grain-fed animals). |
ULTRA CLA 2/day 80% |
|
|
MULTIGENICS |
4/DAY |
100% |
CELAPRO |
1/DAY |
100% |
META 1C3 |
2/DAY |
60% |
CAL APATITE PLUS |
4/DAY |
100% |
E-COMPLEX 1:1 |
2/DAY |
80% |
SPECTRASOY |
1/DAY |
80% |
ULTRA CLA |
2/DAY |
80% |
Aspirin |
One 325mg/day if no contraindication |
|